Droia Ventures
Mathias Declercq is a Senior Associate at Droia Ventures since December 2021, with prior experience as an Associate and Scientific Analyst. Before joining Droia Ventures, Mathias worked as a Doctoral Researcher at VIB from December 2017 to December 2021. An internship in MSc Management was completed at KU Leuven in 2017, and previous internships in MSc Biochemistry & Biotechnology were held at KU Leuven Campus Kulak Kortrijk. Mathias holds a Doctor of Philosophy in Biomedical Sciences from KU Leuven (2017-2021), a Master of Science in Management (2016-2017), a Master of Science in Biochemistry and Biotechnology (2014-2016), and a Bachelor of Science in Biochemistry and Biotechnology from KU Leuven (2011-2014), along with additional master's studies at the University of Gothenburg in 2015.
This person is not in any offices
Droia Ventures
1 followers
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. They invest in novel science and innovative approaches to bring promising drug candidates to patients and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. Droia has an in-house team of experts and drug development professionals who follow the portfolio companies closely and provide hands-on support. Droia invests in early financing rounds and incubates new companies.